Pharmacokinetics
"Pharmacokinetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dynamic and kinetic mechanisms of exogenous chemical and DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.
Descriptor ID |
D010599
|
MeSH Number(s) |
G03.787 G07.690.725
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacokinetics".
Below are MeSH descriptors whose meaning is more specific than "Pharmacokinetics".
This graph shows the total number of publications written about "Pharmacokinetics" by people in this website by year, and whether "Pharmacokinetics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 0 | 1 | 1 | 2001 | 0 | 1 | 1 | 2003 | 0 | 1 | 1 | 2004 | 0 | 1 | 1 | 2007 | 0 | 2 | 2 | 2010 | 0 | 2 | 2 | 2011 | 1 | 0 | 1 | 2012 | 1 | 2 | 3 | 2015 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmacokinetics" by people in Profiles.
-
Frymoyer A, Van Meurs KP, Drover DR, Klawitter J, Christians U, Chock VY. Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Pediatr Res. 2020 12; 88(6):871-877.
-
Harskamp-van Ginkel MW, Hill KD, Becker KC, Becker K, Testoni D, Cohen-Wolkowiez M, Gonzalez D, Barrett JS, Benjamin DK, Siegel DA, Banks P, Watt KM. Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review. JAMA Pediatr. 2015 Jul; 169(7):678-85.
-
Aylward LL, Kirman CR, Adgate JL, McKenzie LM, Hays SM. Interpreting variability in population biomonitoring data: role of elimination kinetics. J Expo Sci Environ Epidemiol. 2012 Jul; 22(4):398-408.
-
Kadam RS, Bourne DW, Kompella UB. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance. Drug Metab Dispos. 2012 Jul; 40(7):1380-8.
-
Joy MS. Impact of glomerular kidney diseases on the clearance of drugs. J Clin Pharmacol. 2012 Jan; 52(1 Suppl):23S-34S.
-
Wu R, Tong C, Wang Z, Mauger D, Tantisira K, Szefler SJ, Chinchilli VM, Israel E. A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics. Drug Discov Today. 2011 Oct; 16(19-20):884-90.
-
Kompella UB, Kadam RS, Lee VH. Recent advances in ophthalmic drug delivery. Ther Deliv. 2010 Sep; 1(3):435-56.
-
Soderquist RG, Mahoney MJ. Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics. Expert Opin Drug Deliv. 2010 Mar; 7(3):285-93.
-
Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007 Jun; 6(2):110-9.
-
Barton KA, Shui YB, Petrash JM, Beebe DC. Comment on: the Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand. 2007 May; 85(3):339-40.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|